Thailand - Delayed Quote THB

MEDEZE_MEDEZE GROUP (MEDEZE-R.BK)

Compare
9.35
-0.95
(-9.22%)
At close: 4:36:47 PM GMT+7

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in THB.
NameTitlePayExercisedYear Born
Dr. Veerapol Khemarangsan Co-Founder, CEO & Director -- -- --
Ms. Supakarn Kijgosol CFO & Director -- -- --
Ms. Phunurai Akkarasacksakun COO & Director -- -- --
Dr. Tanut Kunkanjanawan Ph.D. Chief Laboratory Officer & Director -- -- --
Dr. Rachanee O-charoen Chief Medical Officer & Director -- -- --
Ms. Danita Phithaknetikun Chief Business Development Officer & Director -- -- --

MEDEZE_MEDEZE GROUP

28/9 Moo 8
Phutthamonthon Sai 4 Road Krathum Lom, Sam Phran
Nakhon Pathom, 73220
Thailand
66 9 1599 9999 https://www.medezegroup.com
Sector: 
Healthcare

Description

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells; and research, develops, and collects data on all types of human cellular activities and medical laboratory test. In addition, the company sells dietary supplements, cosmetics, and dermo cosmetics. The company was founded in 2010 and is based in Nakhon Pathom, Thailand.

Corporate Governance

MEDEZE_MEDEZE GROUP’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

November 26, 2024 at 12:00 AM UTC

Ex-Dividend Date